Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed to Hold Business Update Conference Call on February 22, 2021

GlobeNewswire February 9, 2021

PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewswire January 8, 2021

PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules

GlobeNewswire January 6, 2021

PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering

GlobeNewswire December 22, 2020

PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering

GlobeNewswire December 18, 2020

PAVmed Announces Registered Direct Offering of its Common Stock

GlobeNewswire December 11, 2020

PAVmed to Hold Business Update Conference Call on November 17, 2020

GlobeNewswire November 2, 2020

INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating PAVmed Inc. for Potential Breach of Fiduciary Duty Claims

ACCESSWIRE IA October 6, 2020

PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020

GlobeNewswire September 8, 2020

(LD Micro) 360 Companies Set to Present this Week

Accesswire August 31, 2020

PAVmed to Present at The LD 500 Virtual Conference

Accesswire August 27, 2020

PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire August 18, 2020

ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire August 14, 2020

PAVmed Secures $7 Million Convertible Note Financing

GlobeNewswire August 6, 2020

LD Micro Announces Preliminary List of Presenters for the LD-500

Accesswire August 5, 2020

PAVmed to Hold Business Update Conference Call on August 18, 2020

GlobeNewswire July 28, 2020

PAVmed to Present at Maxim Group's COVID-19 Webinar on July 16, 2020

GlobeNewswire July 13, 2020

INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating PAVmed Inc. for Potential Breach of Fiduciary Duty Claims

ACCESSWIRE IA July 7, 2020

PAVmed to Join the Russell 2000® and Russell 3000® Indexes

GlobeNewswire June 17, 2020

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor

GlobeNewswire June 15, 2020